
Employers Face Rising Costs as GLP-1 Weight-Loss Drugs Reshape Health-Benefit Budgets
Surge in Coverage and Cost for GLP-1 Weight-Loss Drugs in the Workplace In recent years, a new class of medications known as glucagon-like peptide-1 (GLP-1) agonists—originally developed for diabetes—have emerged as highly effective treatments for weight loss. These drugs, such as those listed at more than US$1,300 per month for











